Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis
Authors
Keywords
Hepatitis C, Direct-acting antivirals, Qualitative, Indigenous, People who inject drugs, Systematic review
Journal
INTERNATIONAL JOURNAL OF DRUG POLICY
Volume 96, Issue -, Pages 103247
Publisher
Elsevier BV
Online
2021-04-14
DOI
10.1016/j.drugpo.2021.103247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease
- (2020) James M. Paik et al. HEPATOLOGY
- Enablers and barriers for the provision of community‐based HCV treatment: A case study of a real‐world practice
- (2020) Davoud Pourmarzi et al. JOURNAL OF VIRAL HEPATITIS
- Challenges and opportunities in examining and addressing intersectional stigma and health
- (2019) Janet M. Turan et al. BMC Medicine
- Global Elimination of Chronic Hepatitis
- (2019) David L. Thomas NEW ENGLAND JOURNAL OF MEDICINE
- Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience
- (2019) A.D. Marshall et al. DRUG AND ALCOHOL DEPENDENCE
- ‘Hep C’s like the common cold’: Understanding barriers along the HCV care continuum among young people who inject drugs
- (2018) Margie R. Skeer et al. DRUG AND ALCOHOL DEPENDENCE
- Reducing patient and provider knowledge gaps: An evaluation of a community informed hepatitis C online course
- (2018) Terri Buller-Taylor et al. PATIENT EDUCATION AND COUNSELING
- Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era
- (2018) Rachel Sacks-Davis et al. Journal of the International AIDS Society
- Pathways to ensure universal and affordable access to hepatitis C treatment
- (2018) Caitlin H. Douglass et al. BMC Medicine
- Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?
- (2018) Annie Madden et al. PLoS One
- Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
- (2016) Lucy Platt et al. LANCET INFECTIOUS DISEASES
- Physicians’ Attitudes and Practice Toward Treating Injection Drug Users Infected with Hepatitis C Virus: Results from a National Specialist Survey in Canada
- (2016) Angelique Myles et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
- (2013) Jason Grebely et al. JOURNAL OF INFECTIOUS DISEASES
- Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration
- (2010) Davina Swan et al. AIDS PATIENT CARE AND STDS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Methods for the thematic synthesis of qualitative research in systematic reviews
- (2008) James Thomas et al. BMC Medical Research Methodology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More